blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1408896

EP1408896 - PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.11.2016
Database last updated on 20.09.2024
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): CY, TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
CPEX Pharmaceuticals, Inc.
2 Holland Way
Exeter, NH 03833 / US
[2009/11]
Former [2004/19]For all designated states
Bentley Pharmaceuticals, Inc.
Bentley Park, 2 Holland Way
Exeter, NH 03833 / US
Former [2004/17]For all designated states
Bentley Pharmaceuticals, Inc
65 Lafayette Road, 3rd Floor
North Hampton, NH 03862-2403 / US
Inventor(s)01 / GYURIK, Robert, J.
12 Ashbrook Road
Exeter, NH 03833 / US
 [2004/17]
Representative(s)Chajmowicz, Marion
Becker & Associés
25, Rue Louis Le Grand
75002 Paris / FR
[N/P]
Former [2016/03]Chajmowicz, Marion
Becker & Associés
25, rue Louis Le Grand
75002 Paris / FR
Former [2009/30]Chajmowicz, Marion
Cabinet Becker et Associés 25, rue Louis le Grand
75002 Paris / FR
Former [2004/17]Ungria Lopez, Javier, et al
Avda. Ramon y Cajal, 78
28043 Madrid / ES
Application number, filing date02744546.924.06.2002
[2004/17]
WO2002US19849
Priority number, dateUS20010300293P22.06.2001         Original published format: US 300293 P
[2004/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03000158
Date:03.01.2003
Language:EN
[2003/01]
Type: A1 Application with search report 
No.:EP1408896
Date:21.04.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2003 takes the place of the publication of the European patent application.
[2004/17]
Type: B1 Patent specification 
No.:EP1408896
Date:20.01.2016
Language:EN
[2016/03]
Search report(s)International search report - published on:US03.01.2003
(Supplementary) European search report - dispatched on:EP27.01.2010
ClassificationIPC:A61K9/107
[2010/08]
CPC:
A61K9/107 (EP,US); A61K9/0014 (EP,US); A61K9/0043 (EP,US);
A61P25/04 (EP); A61P3/10 (EP); A61K47/22 (EP,US);
A61K47/32 (EP,US) (-)
Former IPC [2004/17]A61F6/06, A61F9/02, A61F13/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2016/03]
Former [2004/17]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG[2004/17]
English:PHARMACEUTICAL COMPOSITION[2004/17]
French:COMPOSITION PHARMACEUTIQUE[2004/17]
Entry into regional phase21.01.2004National basic fee paid 
21.01.2004Search fee paid 
21.01.2004Designation fee(s) paid 
21.01.2004Examination fee paid 
Examination procedure22.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
21.01.2004Examination requested  [2004/17]
20.07.2010Despatch of a communication from the examining division (Time limit: M06)
28.01.2011Reply to a communication from the examining division
31.01.2012Despatch of a communication from the examining division (Time limit: M06)
22.11.2012Reply to a communication from the examining division
02.04.2015Communication of intention to grant the patent
18.09.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
26.11.2015Fee for grant paid
26.11.2015Fee for publishing/printing paid
26.11.2015Receipt of the translation of the claim(s)
Divisional application(s)EP12176710.7   Application refused  : 26.01.2013
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.07.2010
Opposition(s)21.10.2016No opposition filed within time limit [2016/52]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
26.11.2015Request for further processing filed
26.11.2015Full payment received (date of receipt of payment)
Request granted
08.12.2015Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
22.11.2012Request for further processing filed
22.11.2012Full payment received (date of receipt of payment)
Request granted
11.12.2012Decision despatched
Fees paidRenewal fee
21.01.2004Renewal fee patent year 03
14.06.2005Renewal fee patent year 04
14.06.2006Renewal fee patent year 05
14.06.2007Renewal fee patent year 06
31.03.2008Renewal fee patent year 07
02.06.2009Renewal fee patent year 08
11.06.2010Renewal fee patent year 09
13.06.2011Renewal fee patent year 10
14.06.2012Renewal fee patent year 11
27.06.2013Renewal fee patent year 12
30.06.2014Renewal fee patent year 13
26.11.2015Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
30.06.201514   M06   Fee paid on   26.11.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT20.01.2016
BE20.01.2016
CY20.01.2016
DK20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
SE20.01.2016
TR20.01.2016
GR21.04.2016
PT20.05.2016
IE24.06.2016
[2018/29]
Former [2017/38]AT20.01.2016
BE20.01.2016
DK20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
SE20.01.2016
GR21.04.2016
PT20.05.2016
IE24.06.2016
Former [2017/03]AT20.01.2016
BE20.01.2016
DK20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
SE20.01.2016
GR21.04.2016
PT20.05.2016
Former [2016/46]AT20.01.2016
DK20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
SE20.01.2016
GR21.04.2016
PT20.05.2016
Former [2016/39]AT20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
SE20.01.2016
GR21.04.2016
PT20.05.2016
Former [2016/38]AT20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
GR21.04.2016
PT20.05.2016
Former [2016/36]AT20.01.2016
ES20.01.2016
FI20.01.2016
IT20.01.2016
NL20.01.2016
GR21.04.2016
Former [2016/35]ES20.01.2016
FI20.01.2016
NL20.01.2016
GR21.04.2016
Former [2016/30]NL20.01.2016
Documents cited:Search[Y]EP0272097  (NOVO INDUSTRI AS [DK]) [Y] 1-20,24-27 * page 3, line 1 - line 34 * * example - * * claim - *;
 [E]WO03028702  (MACROCHEM CORP [US], et al) [E] 1-5,8,14-17,24 * page 2, line 10 - line 29 * * page 7, line 6 - page 8, line 26 * * example - * * claim - *;
 [Y]  - MITRA RANJANA ET AL, "Lipid emulsions as vehicles for enhanced nasal delivery of insulin", INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON), (20000915), vol. 205, no. 1-2, ISSN 0378-5173, pages 127 - 134, XP002563306 [Y] 1-20,24-27 * abstract * * paragraph [02.3] * * paragraph [0004] *

DOI:   http://dx.doi.org/10.1016/S0378-5173(00)00506-8
 [A]  - TAKALA A ET AL, "Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone", ACTA ANAESTHESIOLOGICA SCANDINAVICA, (1997), vol. 41, no. 2, ISSN 0001-5172, pages 309 - 312, XP002563307 [A] 1-27 * abstract * * page 312, paragraph l *

DOI:   http://dx.doi.org/10.1111/j.1399-6576.1997.tb04684.x
International search[Y]US5023252  (HSEIH DEAN [US]);
 [Y]US5989535  (NAYAK SMITA [US])
Examination   - BIBETTE J ET AL, "Stability Criteria for Emulsions", PHYSICAL REVIEW LETTERS, AMERICAN PHYSICAL SOCIETY, NEW YORK, US, (19921019), vol. 69, no. 16, doi:10.1103/PHYSREVLETT.69.2439, ISSN 0031-9007, pages 2439 - 2443, XP003014313

DOI:   http://dx.doi.org/10.1103/PhysRevLett.69.2439
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.